Northeast Financial Group Inc. boosted its position in NEXGEL, Inc. (NASDAQ:NXGL – Free Report) by 168.8% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 31,848 shares of the company’s stock after acquiring an additional 20,000 shares during the period. Northeast Financial Group Inc. owned about 0.50% of NEXGEL worth $82,000 at the end of the most recent reporting period.
NEXGEL Stock Down 3.8 %
Shares of NASDAQ NXGL opened at $3.06 on Friday. The stock has a market capitalization of $19.35 million, a PE ratio of -5.28 and a beta of 0.73. NEXGEL, Inc. has a 52-week low of $1.71 and a 52-week high of $3.55. The firm has a fifty day moving average of $2.81 and a 200-day moving average of $2.54. The company has a quick ratio of 0.81, a current ratio of 1.36 and a debt-to-equity ratio of 0.22.
NEXGEL (NASDAQ:NXGL – Get Free Report) last posted its quarterly earnings results on Monday, August 19th. The company reported ($0.14) EPS for the quarter. The company had revenue of $1.44 million for the quarter. NEXGEL had a negative net margin of 52.60% and a negative return on equity of 71.26%.
About NEXGEL
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
See Also
- Five stocks we like better than NEXGEL
- Trading Stocks: RSI and Why it’s Useful
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Stock Market Upgrades: What Are They?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Manufacturing Stocks Investing
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding NXGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NEXGEL, Inc. (NASDAQ:NXGL – Free Report).
Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.